Pharmafile Logo

Biosimilars in 2018: EU doctors’ perceptions of RA drug market

January 6, 2016 | RA Patients, biosimilars 

Published in pharmaphorum October 2015 by Laurent Chanroux

Physicians in Europe’s Big 5 think current market leaders will continue to lead, with biosimilars making the greatest inroads in the field up to 2018, if clearer guidance on efficacy and safety is provided.

A panel of around 200 physicians treating RA across Europe (France, Germany, Italy, Spain and the UK) were asked how they currently treat their patients and what they expect to be doing in 2018. The findings suggest that the market leaders can breathe easy, for the moment at least.

Read the full article here:
www.researchpartnership.com/news/2015/10/article-biosimilars-in-2018-ra-perceptions/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Patient Power: Too Much of a Good Thing?

Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding

Webinar: Mobile Research in Asia and Emerging Markets

Current statistics around mobile technology reveal that many physicians in Asia are now using smartphones, tablets and other mobile devices to assist them in their daily practices. In China alone,73%...

Webinar: Understanding the Patient Journey in Order to Influence Prescribing Decisions

Using real data, this webinar looks at the increasingly popular view that says we need to understand more about the patient and the relationship they have with their physicians in...

Webinar: Focus on China: Conducting Research in the World’s Fastest Growing Pharma Market

This webinar looks to provide market research professionals with an overview of the Chinese healthcare market and provide participants with top tips for conducting relevant and effective market research in...

Webinar: Prescription Rationale: Physician Research via an iPhone App

This webinar explores the potential of using smartphone Apps as a platform for collecting detailed qualitative insights into physicians' decision rationale at the moment of prescription.

Maximising patient adherence by leveraging the patient/ physician/ pharma relationship

Director Marc Yates looks at the problem of patient compliance - can a better understanding of patient attitudes, needs and behaviours help pharma develop strategies to improve adherence?

Digital research in Asia

Director Marc Yates uses findings from a study conducted in six markets in Asia to explore how digital channels are being utilised by consumers and look at the digital opportunities...

Achieving customer centricity – Using immersion techniques to get closer to the pulse of the customer

Director Marc Yates discusses the importance of being customer-centric in the pharmaceutical industry and how immersion techniques in market research can help develop a better understanding of the customer.

The Mobile Revolution – Using mobile Apps to deliver “in-the-moment” market research to global healthcare

Director John Branston investigates the use of mobile research in order to capture immediate detailed, qualitative insights into prescription rationale at the patient level.